99% Savings - Buy Just @1 Rs X
Pentasa Prolonged Release Granules 1 GM is a prescription medicine that is available as a Powder. It is primarily used for the treatment of Ulcerative Colitis.
The optimal dosage of Pentasa Prolonged Release Granules 1 GM is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Some other side effects of Pentasa Prolonged Release Granules 1 GM have been listed ahead. Usually, these side effects of Pentasa Prolonged Release Granules 1 GM go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Pentasa Prolonged Release Granules 1 GM's effect is Safe during pregnancy and Mild for lactating mothers. It is important to know if Pentasa Prolonged Release Granules 1 GM has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Pentasa Prolonged Release Granules 1 GM related warnings section.
Some other conditions that can be affected by Pentasa Prolonged Release Granules 1 GM are listed in the contraindications section below.
Additionally, Pentasa Prolonged Release Granules 1 GM may also adversely react with other medicines. A complete list of these interactions is given below.
In addition to the above precautions for Pentasa Prolonged Release Granules 1 GM, it is important to know that it is not safe while driving, and is not habit-forming.
Pentasa Prolonged Release Granules 1 GM is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Pentasa Prolonged Release Granules 1 GM safe for pregnant women?
Pregnant women can take Pentasa safely.
Is the use of Pentasa Prolonged Release Granules 1 GM safe during breastfeeding?
Breastfeeding women can take Pentasa as it bears very minor side effects for them.
What is the effect of Pentasa Prolonged Release Granules 1 GM on the Kidneys?
Very few cases of side effects of Pentasa on kidney have been reported.
What is the effect of Pentasa Prolonged Release Granules 1 GM on the Liver?
Pentasa has very mild side effects on the liver.
What is the effect of Pentasa Prolonged Release Granules 1 GM on the Heart?
Pentasa is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Pentasa Prolonged Release Granules 1 GM unless your doctor advises you to do so -
Is this Pentasa Prolonged Release Granules 1 GM habit forming or addictive?
Pentasa Prolonged Release Granules 1 GM does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Pentasa Prolonged Release Granules 1 GM can make you feel drowsy.
Is it safe?
Yes, Pentasa Prolonged Release Granules 1 GM is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Pentasa Prolonged Release Granules 1 GM is unable to treat or cure mental disorders.
Interaction between Food and Pentasa Prolonged Release Granules 1 GM
You can take Pentasa Prolonged Release Granules 1 GM with food.
Interaction between Alcohol and Pentasa Prolonged Release Granules 1 GM
No research has been done on this till date. Therefore, it is not known what the effect of taking Pentasa Prolonged Release Granules 1 GM with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Asacol® (mesalamine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 684
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 820-822